Senju Pharmaceutical and DKSH expand partnership to drive growth in Thailand September 17, 2020


			
				Senju Pharmaceutical and DKSH expand partnership to drive growth in Thailand

Following the successful market expansion in Vietnam, Senju and DKSH have announced their expanded partnership to provide Thai patients with treatments for eye diseases.

Media release

Senju Pharmaceutical and DKSH expand partnership to drive growth in Thailand

Following the successful market expansion in Vietnam, Senju and DKSH have announced their expanded partnership to provide Thai patients with treatments for eye diseases.

Bangkok, September 17, 2020 – DKSH Business Unit Healthcare, Asia’s leading partner for healthcare companies, and Senju Pharmaceutical, Japan’s leading company specializing in ophthalmology, have entered into a collaboration to bring Senju’s cataract treatment to hospitals, clinics and pharmacies across Thailand.

 

Senju Pharmaceutical and DKSH have already been partnering in Vietnam since April 2018. The expanded collaboration in Thailand emphasizes the long-standing relationship between the two companies and reinforces the strong position and presence of DKSH in Asia.

 

Yoshida Shuhei, President of Senju Pharmaceutical, said: “It is an honor to extend the strategic partnership with DKSH. The company offers all key services along the entire value chain and has extensive local and global networks. Our mission is to contribute to the eye health of people around the world, and we aim to create superior pharmaceutical products that enable people to sense the joy of life. We believe that DKSH is the right partner to transform our mission into reality in Thailand.”

 

John Clare, Vice President, Healthcare, DKSH Thailand and Indochina, said: “We are proud to partner with Senju Pharmaceutical in Thailand, a company which, like us, is committing to enriching people’s lives. With a broad reach across pharmacy and medical channels in Thailand, we are dedicated to drive the expansion for Senju’s eye disease treatment for the health and well-being of Thai patients.”